Article abstracts are available by clicking the PMID reference and article reprints can be obtained by contacting us at info@kalvista.com

Clermont A, Chilcote TJ, Kita T, Liu J, Riva P, Sinha S and Feener EP. Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats. Diabetes. 2011;60(5):1590-8. PMID:21444925

Liu J, Gao B-B, Clermont AC, Blair P, Chilcote TJ, Sinha S, Flaumenhaft R and Feener EP. Hyperglycemia induced cerebral hematoma expansion is mediated by plasma kallikrein. Nature Medicine. 2011 Feb;17(2):206-10. PMID:21258336

Feener EP. Plasma kallikrein and diabetic macular edema. Curr. Diab. Rep. 2010 Aug;10(4):270-5. PMID: 20535647

Phipps JA, Clermont AC, Sinha S, Chilcote TJ, Bursell S-E and Feener EP. Plasma kallikrein mediates angiotensin AT1 receptor stimulated retinal vascular permeability. Hypertension 2009 Feb;53(2):175-81 PMID:19124682

Phipps JA and Feener EP. The kallikrein-kinin system in diabetic retinopathy: Lessons for the kidney. Kidney Int., 2008;73(10):1114-9. PMID:18272958

Gao BB, Clermont A, Rook S, Fonda SJ, Srinivasan VJ, Wojtkowski M, Fujimoto JG, Avery RL, Arrigg PG, Bursell SE, Aiello LP and Feener EP. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nature Medicine. 2007 Feb;13(2):181-8. PMID:17259996